Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5962714 | 0.82 | PPARD (0.36) | TSHRSMN1; SMN2TP53TDP1PPARD | |
| SCHEMBL2986782 | 0.81 | HTT (0.31) | — | |
| SCHEMBL10704347 | 0.80 | MAPT (0.40) | TSHRCYP3A4 | |
| SCHEMBL18048498 | 0.80 | TSHR (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL14105288 | 0.78 | TSHR (0.40) | TSHRSMN1; SMN2TP53TDP1PPARD | |
| SCHEMBL2079486 | 0.77 | TSHR (0.39) | TSHRSMN1; SMN2TP53TDP1PPARD | |
| SCHEMBL8820544 | 0.77 | TSHR (0.39) | TSHRSMN1; SMN2TP53TDP1PPARD | |
| SCHEMBL1683251 | 0.75 | TSHR (0.37) | TSHRSMN1; SMN2TP53TDP1PPARD | |
| SCHEMBL6553791 | 0.73 | TSHR (0.36) | TSHRSMN1; SMN2TP53TDP1PPARD | |
| SCHEMBL905270 | 0.73 | TSHR (0.36) | TSHRSMN1; SMN2TP53TDP1PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001951-B1 | THIAZOLE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND USE | SCHERING AG (DE) | 2002-09-25 | — | — | EP | claimed |
| US-6384230-B1 | 2,6-DIMETHYL-5-((4-ETHOXYPHENYL)-METHOXY)-7-(2-METHYLTHIAZOL-4-YL)HEPTA -2,6-DIENOIC ACID ETHYL ESTER FROM MALIC ACID, WITTIG REACTION WITH 2-METHYL-4-THIAZOLYLMETHYL TRIPHENYL PHOSPHONIUM BROMIDE; INTERMEDIATES FOR EPOTHILONE A OR B | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | claimed |
| CN-107427699-A | For treating the KDM1A inhibitor of disease | 伊美格生物科学公司 | 2017-12-01 | — | — | CN | disclosed |
| EP-2697191-B1 | BRANCHED 3-PHENYLPROPIONIC ACID DERIVATIVES AND THE USE THEREOF | BAYER IP GMBH (DE) | 2015-11-18 | — | — | EP | disclosed |
| EP-1001951-B1 | THIAZOLE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND USE | SCHERING AG (DE) | 2002-09-25 | — | — | EP | disclosed |
| EP-1001951-A1 | THIAZOLE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND USE | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003848-A1 | THIAZOLE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND USE | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-01-28 | — | — | WO | disclosed |
| EP-0000833-B1 | DERIVATIVES OF PHOSPHONOACYL PROLINES AND THEIR PHARMACEUTICAL USE | E.R. Squibb & Sons, Inc. (US) | 1981-09-02 | — | — | EP | disclosed |
| US-4151172-A | Phosphonoacyl prolines and related compounds | E. R. SQUIBB & SONS, INC. (US) | 1979-04-24 | — | — | US | disclosed |
| EP-0000833-A1 | Derivatives of phosphonoacyl prolines and their pharmaceutical use | E.R. Squibb & Sons, Inc. (US) | 1979-02-21 | — | — | EP | disclosed |